Ping Li

Ping Li is a Senior Principal Scientist in the DMPK department at C4 Therapeutics, Inc. Prior to this role, Ping held positions at companies such as FORMA Therapeutics, Biogen, Millennium Pharmaceuticals, and ARIAD Pharmaceuticals, gaining expertise in DMPK. Ping has a Ph.D. and a Master's Degree in Pharmaceutical Sciences from West Virginia University, as well as a Master's degree in Chemistry from Sichuan University. Ping has extensive experience in providing DMPK support in discovery programs, conducting in vitro and in vivo ADME and PK studies, and transitioning compounds into development for various indications. Ping has a strong background in enzymatic kinetics, CYP inhibition studies, and bioanalytical techniques.